Novo Nordisk sued Eli Lilly, alleging misleading ads unfairly compare doses of Zepbound and Mounjaro with Wegovy and Ozempic.
4hon MSN
The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
Kuckelman said Lilly's advertisements compare weight-loss results of about 50 pounds for Zepbound with about 33 pounds for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results